Director of HematologyPrincess Alexandra HospitalWoolloongabba, Queensland, Australia
OC 13.3 - Pooled Analysis of the Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients With Previously Treated Immune Thrombocytopenia: Phase 2 Study
Sunday, June 23, 202410:00 – 10:15 ICT
OC 45.4 - Investigating a family with severe inherited thrombocytopenia reveals a novel structural variant involving ANKRD26
Monday, June 24, 202415:30 – 15:45 ICT
